| Spirig HealthCare AG - Tadalafil Spirig HC, 2.5 mg, Filmtabletten | | 67625 | | 01 | | Tadalafil Spirig HC, 2.5 mg | | Filmtabletten | | G04BE08 | | Tadalafil | | 23.07.2020 | | |
| | Composition | | tadalafilum 2.5 mg, lactosum monohydricum 28.65 mg, croscarmellosum, natrii laurilsulfas, hydroxypropylcellulosum, polysorbatum 80, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 420 µg, E 171, triacetinum, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 209.8 µg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Tadalafilum | 2.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Croscarmellosum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 420 µg | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | | | Triacetinum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 012 | 28 | DDP | DDP | B | | Oui |
|
|
